Texas AG prevails over acai firm
This article was originally published in The Tan Sheet
Executive SummaryAustin Hilton and his firm FXsupplements.com will no longer ship unauthorized orders to customers, make false health claims or refrain from clearly disclosing the terms of service to customers, under a final judgment and permanent injunction entered into July 20. Arlington, Texas-based Hilton will also refund customers he overcharged for his acai berry supplement products -- which he advertised as reducing the risk of cancer, heart disease and Alzheimer's disease -- Texas Attorney General Greg Abbott announced July 21
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.